ALPHA & OMEGA SEMICONDUCTOR (AOSL)

BMG6331P1041 - Common Stock

38.63  -1.77 (-4.38%)

After market: 41.5999 +2.97 (+7.69%)

Fundamental Rating

3

Taking everything into account, AOSL scores 3 out of 10 in our fundamental rating. AOSL was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. While AOSL seems to be doing ok healthwise, there are quite some concerns on its profitability. AOSL is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

AOSL had positive earnings in the past year.
AOSL had a positive operating cash flow in the past year.
In multiple years AOSL reported negative net income over the last 5 years.
In the past 5 years AOSL always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of -0.97%, AOSL perfoms like the industry average, outperforming 42.59% of the companies in the same industry.
AOSL has a Return On Equity (-1.24%) which is in line with its industry peers.
Industry RankSector Rank
ROA -0.97%
ROE -1.24%
ROIC N/A
ROA(3y)11.66%
ROA(5y)8.09%
ROE(3y)17.74%
ROE(5y)13.31%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

AOSL has a Gross Margin of 26.15%. This is in the lower half of the industry: AOSL underperforms 70.37% of its industry peers.
AOSL's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AOSL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.64%
GM growth 5Y0.44%

4

2. Health

2.1 Basic Checks

AOSL does not have a ROIC to compare to the WACC, probably because it is not profitable.
AOSL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, AOSL has more shares outstanding
The debt/assets ratio for AOSL has been reduced compared to a year ago.

2.2 Solvency

An Altman-Z score of 4.37 indicates that AOSL is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.37, AOSL is in line with its industry, outperforming 58.33% of the companies in the same industry.
AOSL has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
AOSL's Debt to Equity ratio of 0.03 is fine compared to the rest of the industry. AOSL outperforms 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 4.37
ROIC/WACCN/A
WACC14.65%

2.3 Liquidity

A Current Ratio of 2.58 indicates that AOSL has no problem at all paying its short term obligations.
AOSL has a Current ratio (2.58) which is comparable to the rest of the industry.
AOSL has a Quick Ratio of 1.31. This is a normal value and indicates that AOSL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.31, AOSL is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.31

3

3. Growth

3.1 Past

The earnings per share for AOSL have decreased strongly by -48.98% in the last year.
AOSL shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.80% yearly.
Looking at the last year, AOSL shows a decrease in Revenue. The Revenue has decreased by -0.75% in the last year.
The Revenue has been growing slightly by 7.83% on average over the past years.
EPS 1Y (TTM)-48.98%
EPS 3Y-40.34%
EPS 5Y-12.8%
EPS Q2Q%-36.36%
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y0.02%
Revenue growth 5Y7.83%
Sales Q2Q%0.69%

3.2 Future

AOSL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.75% yearly.
The Revenue is expected to grow by 6.18% on average over the next years.
EPS Next Y-19.93%
EPS Next 2Y29.75%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.18%
Revenue Next 2Y6.18%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 77.26 indicates a quite expensive valuation of AOSL.
AOSL's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of AOSL to the average of the S&P500 Index (29.20), we can say AOSL is valued expensively.
The Price/Forward Earnings ratio is 37.01, which means the current valuation is very expensive for AOSL.
AOSL's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 24.00. AOSL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 77.26
Fwd PE 37.01

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AOSL is valued a bit cheaper than the industry average as 70.37% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.78

4.3 Compensation for Growth

AOSL's earnings are expected to grow with 29.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.75%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AOSL!.
Industry RankSector Rank
Dividend Yield N/A

ALPHA & OMEGA SEMICONDUCTOR

NASDAQ:AOSL (11/22/2024, 8:23:23 PM)

After market: 41.5999 +2.97 (+7.69%)

38.63

-1.77 (-4.38%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.12B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 77.26
Fwd PE 37.01
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -1.24%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 26.15%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.58
Quick Ratio 1.31
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-48.98%
EPS 3Y-40.34%
EPS 5Y
EPS Q2Q%
EPS Next Y-19.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-0.75%
Revenue growth 3Y0.02%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y